Quantitative protein mass-spectrometry requires a standardized pre-analytical phase

Autor: Smit, N.P.M., Romijn, F.P.H.T.M., Ham, V.J.J. van, Reijnders, E., Cobbaert, C.M., Ruhaak, L.R.
Rok vydání: 2022
Předmět:
Zdroj: Clinical Chemistry and Laboratory Medicine. WALTER DE GRUYTER GMBH
Clinical Chemistry and Laboratory Medicine
ISSN: 1437-4331
Popis: Objectives Quantitative protein mass-spectrometry (QPMS) in blood depends on tryptic digestion of proteins and subsequent measurement of representing peptides. Whether serum and plasma can be used interchangeably and whether in-vitro anticoagulants affect the recovery is unknown. In our laboratory serum samples are the preferred matrix for QPMS measurement of multiple apolipoproteins. In this study, we investigated the effect of different matrices on apolipoprotein quantification by mass spectrometry. Methods Blood samples were collected from 44 healthy donors in Beckton Dickinson blood tubes simultaneously for serum (with/without gel) and plasma (heparin, citrate or EDTA). Nine apolipoproteins were quantified according to standard operating procedure using value-assigned native serum calibrators for quantitation. Tryptic digestion kinetics were investigated in the different matrices by following formation of peptides for each apolipoprotein in time, up to 22 h. Results In citrate plasma recovery of apolipoproteins showed an overall reduction with a bias of −14.6%. For heparin plasma only −0.3% bias was found compared to serum, whereas for EDTA-plasma reduction was more pronounced (−5.3% bias) and variable with >14% reduction for peptides of apoA-I, A-II and C-III. Digestion kinetics revealed that especially slow forming peptides showed reduced formation in EDTA-plasma. Conclusions Plasma anticoagulants affect QPMS test results. Heparin plasma showed comparable results to serum. Reduced concentrations in citrate plasma can be explained by dilution, whereas reduced recovery in EDTA-plasma is dependent on altered proteolytic digestion efficiency. The results highlight the importance of a standardized pre-analytical phase for accurate QPMS applications in clinical chemistry.
Databáze: OpenAIRE